As the number of types of COVID-19 Variants of Concern and of Interest increases, fast high throughput NGS sequencing is key to identify new variants while mutation specific PCR testing enables immediate detection and contact tracing.  Eurofins continues to develop innovative COVID-19 testing solutions and has now reached two important milestones. Eurofins has sequenced more than 125,000 … [Read more...] about Eurofins expands its global sequencing and mutation-specific PCR capabilities to detect COVID-19 Variants of Concern and of Interest

Eurofins Scientific (EUFI.PA), a global scientific leader in bioanalytical testing announces the acquisition of Beacon Discovery, a preeminent drug discovery and contract research organization (CRO) focused on G-Protein Coupled Receptor (GPCR) research. Beacon Discovery joins Eurofins Discovery, a market leading CRO with the broadest portfolio of validated in vitro pharmacology, ADMET*, and … [Read more...] about Eurofins Scientific Announces Acquisition of Beacon Discovery, Substantially Expanding Its Integrated Drug Discovery Capabilities and Expertise

Launch of the GSD NovaPrime® SARS-CoV-2 Direct RT-PCR The GSD NovaPrime® SARS-CoV-2 Direct RT-PCR is intended for the qualitative detection of SARS-CoV-2 from human nasopharyngeal swabs, eluted directly into deionised water without an additional RNA extraction process (extraction-free). Increase of global SARS-CoV-2 testing worldwide has posed new challenges to laboratories in nearly all … [Read more...] about Eurofins Launches New ultra-fast Extraction-free RT-PCR Method and Upgrades its RT-PCR Assay for Use with Pharynx Gargle and Saliva Sample Matrices

Eurofins is making new assays for the identification of B.1.1.7 (UK) and B.1.351 (South Africa)/B.1.1.248 (Brazil) variants with a one hour run time available for free to public health institutions who do not have capabilities to rapidly identify the presence of these variants. SARS-CoV-2 belongs to a group of RNA viruses that exhibit spontaneous mutations. Some alarming variants have recently … [Read more...] about Eurofins donates 100,000 fast PCR tests to detect SARS-CoV-2 variants B.1.1.7 (ex. UK), B.1.351 (ex. South Africa) and B1.1.248 (ex. Brazil) to hospitals around the world

The increasing diversity of SARS-CoV-2 variants and the potential higher infectivity of some new viral strains, underline the need to identify, trace and track mutations across the complete viral genome. Currently, strains of concern include the B.1.1.7 variant, first identified in the United Kingdom, and the B.1.351 variant, first identified in South Africa. Eurofins is pleased to announce the … [Read more...] about Eurofins launches new tests and massive capacity for detecting and monitoring new variants of SARS-CoV-2

Eurofins Genomics launches an optimized, cost-effective, SARS-CoV-2, next-generation sequencing service providing full length viral genome sequences. The best-in-class ARTIC NGS Oligo mix synthesized by Eurofins Genomics’ Synthesis branch will also be commercially available shortly. The new NGS service and ARTIC NGS oligo kit are Eurofins’ latest additions to a comprehensive product portfolio to … [Read more...] about Eurofins Genomics launches cost-effective SARS-CoV-2 full-length viral genome sequencing services essential in the identification of viral mutations

On 19 October 2020 Eurofins launched EmpowerDX SARS CoV 2 RT PCR test with at home sampling option after it received an Emergency Use Authorization (EUA) by the FDA. Demand for the testing kit available at empowerdxlab.com is increasing significantly week on week. To make patient sampling easier by non-healthcare professionals and especially for testing children, Eurofins validated a sampling … [Read more...] about Eurofins launches COVID-19 PCR tests with at-home self-sampling options in Europe and donates sequencing capacity to identify VUI-2020-12/01 strain reported to spread faster in the UK

Eurofins announces that its FDA-authorized At-Home COVID-19 Nasal PCR Test is now being covered by Medicare, Medicaid and commercial insurance providers.  The Emergency Use Authorization (“EUA”) authorized self-collection kit gives consumers a minimally invasive, convenient and quick option to test from the comfort of their home.  Results are provided via email link within 24 hours of sample … [Read more...] about Eurofins U.S. Clinical Diagnostic Laboratories Partner with Insurance Providers to Cover FDA-Authorized At-Home COVID-19 Test

Eurofins Central Laboratory, headquartered in Lancaster, Pennsylvania and a member of Eurofins Scientific, a global leader in testing and laboratory services, joined the COVID-19 Pennsylvania testing program after State Health Secretary Dr. Rachel Levine ordered the testing of nursing home residents and staff in the state. Eurofins Lancaster site was founded in 1961 and has become an industry … [Read more...] about Eurofins providing COVID-19 analytical testing and services for Pennsylvania Long Term Care Facilities and vulnerable population citizens

Eurofins U.S. Clinical Diagnostics announced the launch date of its pooled PCR test to detect SARS-CoV-2 and significantly reduce the price per PCR test for clients. Pooling tests, historically used in blood banks, can now be used by the myriad of industries seeking a highly accurate and cost-effective means to conduct COVID-19 testing. Those industries include corporations, sports organizations, … [Read more...] about Eurofins Clinical Diagnostics Launches Lower Cost Highly Accurate COVID-19 PCR Test